Table 5.
Pathway Type | Function | Count | p | Benjamini | |
---|---|---|---|---|---|
Cluster 1: Insulin Functioning | |||||
ES: 1.91 * | KEGG | Insulin resistance | 11 | 0.0023 | 0.17 |
KEGG | AMPK signaling pathway | 11 | 0.0055 | 0.21 | |
KEGG | Insulin signaling pathway | 11 | 0.013 | 0.25 | |
KEGG | FoxO signaling pathway | 8 | 0.14 | 0.56 | |
Cluster 2: NOTCH Functioning | |||||
ES: 1.83 * | REACTOME | Constitutive signaling by NOTCH1 HD+PEST domain mutants | 8 | 0.0017 | 0.25 |
REACTOME | Constitutive signaling by NOTCH1 PEST domain mutants | 8 | 0.0017 | 0.25 | |
REACTOME | NOTCH1 intracellular domain regulates transcription | 6 | 0.014 | 0.65 | |
KEGG | Notch signaling pathway | 6 | 0.018 | 0.29 | |
REACTOME | Notch-HLH transcription pathway | 3 | 0.059 | 0.85 | |
REACTOME | Pre-NOTCH transcription and translation | 3 | 0.22 | 0.98 | |
Cluster 3: Cell Signal Functioning | |||||
ES: 1.31 * | REACTOME | PIP3 activates AKT signaling | 8 | 0.012 | 0.71 |
REACTOME | CD28 dependent PI3K/Akt signaling | 4 | 0.029 | 0.77 | |
REACTOME | Constitutive signaling by AKT1 E17K in cancer | 4 | 0.04 | 0.8 | |
REACTOME | VEGFR2 mediated vascular permeability | 3 | 0.22 | 0.98 |
Clusters created using the DAVID (http://david.abcc.ncifcrf.gov/) Gene Functional Classification Tool and KEGG and REACTOME pathways. ES: enrichment score; Benjamini: Benjamini–Hochberg false discovery rate method; AKT: protein kinase B; AMPK: adenosine monophosphate-activated protein kinase; CD28: Cluster of Differentiation 28; PIP3: phosphatidylinositol-3,4,5-triphosphate; PI3K phosphatidylinositol 3-kinase; VEGFR2: Vascular endothelial growth factor receptor 2; (p-values ≤ 0.05). * Significant ES.